抗血管生成治疗已经成为治疗恶性血液疾病的重要策略。
The generation and development of hematological malignancies are close related to vasculogenesis, so it is an important tactic of anti-vessel growth therapy in hematological malignancies.
由于抗血管生成药物具有毒性低、不易产生获得性耐药的特点。因此，通过抑制血管生成来抑制肿瘤生长成为目前肿瘤治疗的策略之一。
As the features of angiogenesis inhibitors are of low toxicity and have less acquired resistance, it comes to a new strategy to suppress tumor growth by restraining angiogenesis.
应用推荐